LENZ THERAPEUTICS INCLENZ
ASignal's systematic analysis rates LENZ as Bearish.
Reflects the latest available analysis · analyzed Oct 3, 2026
The case on LENZ
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong gross margin of 91.74%
- High cash position with debt-to-equity of 0.00x
- Current ratio of 13.55x indicating strong liquidity
- RSI at 20.13 suggesting potential oversold condition
- Negative operating margin of -622.89%
- Negative return on equity (-59.21%) and return on assets (-37.36%)
- Negative enterprise value and ev_to_revenue ratio of -4.98x indicating financial instability
- Price below 20-day and 50-day moving averages with negative momentum
- No news coverage or Reddit mentions indicating low market interest
See the full verdict on LENZ
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes LENZ
Most investors never get a second opinion, let alone several. ASignal runs LENZ past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.